Drug Shortage Report for CETROTIDE
Report ID | 161102 |
Drug Identification Number | 02247766 |
Brand name | CETROTIDE |
Common or Proper name | Cetrorelix for Injection |
Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Market Status | MARKETED |
Active Ingredient(s) | CETRORELIX |
Strength(s) | 0.25MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | Vial (2mL) |
ATC code | H01CC |
ATC description | HYPOTHALAMIC HORMONES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-23 |
Estimated end date | 2022-08-15 |
Actual end date | 2022-08-16 |
Shortage status | Resolved |
Updated date | 2022-08-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-08-17 | French | Compare |
v7 | 2022-08-17 | English | Compare |
v6 | 2022-06-28 | French | Compare |
v5 | 2022-06-28 | English | Compare |
v4 | 2022-05-24 | English | Compare |
v3 | 2022-05-21 | French | Compare |
v2 | 2022-05-21 | French | Compare |
v1 | 2022-05-21 | English | Compare |
Showing 1 to 8 of 8